$TRXDW

2015 Q2 Form 10-Q Financial Statement

#000119312515174708 Filed on May 06, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2015 Q1 2014 Q1
Revenue $0.00 $0.00 $93.00K
YoY Change -100.0% -100.0% -71.73%
Cost Of Revenue $0.00 $220.0K
YoY Change -100.0% -75.06%
Gross Profit $0.00 -$127.0K
YoY Change -100.0% -77.03%
Gross Profit Margin -136.56%
Selling, General & Admin $2.363M $2.230M $2.020M
YoY Change -0.46% 10.4% 68.76%
% of Gross Profit
Research & Development $6.579M $7.484M $5.011M
YoY Change -16.53% 49.35% 80.19%
% of Gross Profit
Depreciation & Amortization $380.0K $265.0K $290.0K
YoY Change 26.67% -8.62% -17.14%
% of Gross Profit
Operating Expenses $8.942M $9.714M $7.031M
YoY Change -12.81% 38.16% 76.75%
Operating Profit -$9.068M -$9.839M -$7.158M
YoY Change -12.65% 37.45% 57.98%
Interest Expense $280.0K $281.0K $321.0K
YoY Change 35.92% -12.46% 30.49%
% of Operating Profit
Other Income/Expense, Net -$280.0K -$281.0K -$321.0K
YoY Change 35.92% -12.46% 30.49%
Pretax Income -$9.348M -$10.12M -$7.479M
YoY Change -11.7% 35.31% 56.46%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$9.348M -$10.12M -$7.479M
YoY Change -11.7% 35.31% 56.56%
Net Earnings / Revenue -8041.94%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.78 -$2.06 -$1.99
COMMON SHARES
Basic Shares Outstanding 65.61M shares 63.38M shares 244.3M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q2 2015 Q1 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $71.10M $28.40M $8.600M
YoY Change 35.17% 230.23% 377.78%
Cash & Equivalents $71.11M $28.38M $4.160M
Short-Term Investments $4.500M
Other Short-Term Assets $586.0K $644.0K $771.0K
YoY Change -5.02% -16.47% 671.0%
Inventory $651.0K
Prepaid Expenses
Receivables $8.000K $53.00K $52.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $71.71M $29.07M $10.18M
YoY Change 33.49% 185.71% 182.67%
LONG-TERM ASSETS
Property, Plant & Equipment $2.914M $3.010M $1.891M
YoY Change 20.76% 59.18% 530.33%
Goodwill $93.84M $93.84M $93.84M
YoY Change 0.0% 0.0%
Intangibles $1.997M $2.123M $2.625M
YoY Change -20.09% -19.12%
Long-Term Investments
YoY Change
Other Assets $90.00K $52.00K $105.0K
YoY Change 25.0% -50.48%
Total Long-Term Assets $98.84M $99.28M $98.71M
YoY Change -0.24% 0.57% 32804.33%
TOTAL ASSETS
Total Short-Term Assets $71.71M $29.07M $10.18M
Total Long-Term Assets $98.84M $99.28M $98.71M
Total Assets $170.6M $128.4M $108.9M
YoY Change 11.62% 17.87% 2692.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.606M $2.278M $1.900M
YoY Change -55.59% 19.89% 72.73%
Accrued Expenses $2.259M $1.626M $1.531M
YoY Change 18.52% 6.21%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.500M $1.500M $4.000M
YoY Change -39.02% -62.5%
Total Short-Term Liabilities $6.352M $5.444M $7.354M
YoY Change -33.65% -25.97% 568.55%
LONG-TERM LIABILITIES
Long-Term Debt $7.400M $8.400M $3.600M
YoY Change 196.0% 133.33%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $7.400M $8.400M $3.600M
YoY Change 196.0% 133.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.352M $5.444M $7.354M
Total Long-Term Liabilities $7.400M $8.400M $3.600M
Total Liabilities $13.78M $13.80M $10.93M
YoY Change 13.82% 26.27% 893.82%
SHAREHOLDERS EQUITY
Retained Earnings -$155.4M -$146.0M -$105.7M
YoY Change 33.57% 38.1%
Common Stock $312.2M $260.6M $203.7M
YoY Change 21.45% 27.92%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $156.8M $114.5M $97.96M
YoY Change
Total Liabilities & Shareholders Equity $170.6M $128.4M $108.9M
YoY Change 11.62% 17.87% 2692.03%

Cashflow Statement

Concept 2015 Q2 2015 Q1 2014 Q1
OPERATING ACTIVITIES
Net Income -$9.348M -$10.12M -$7.479M
YoY Change -11.7% 35.31% 56.56%
Depreciation, Depletion And Amortization $380.0K $265.0K $290.0K
YoY Change 26.67% -8.62% -17.14%
Cash From Operating Activities -$7.920M -$8.210M -$6.460M
YoY Change 14.78% 27.09% 79.44%
INVESTING ACTIVITIES
Capital Expenditures $150.0K $155.0K $187.0K
YoY Change -79.17% -17.11% 171.01%
Acquisitions
YoY Change
Other Investing Activities $0.00 $1.720M
YoY Change -100.0% 89.01%
Cash From Investing Activities -$150.0K -$160.0K $1.540M
YoY Change -104.01% -110.39% 83.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $46.40M $1.783M
YoY Change -11.45%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 50.80M 1.980M -930.0K
YoY Change -1.47% -312.9%
NET CHANGE
Cash From Operating Activities -7.920M -8.210M -6.460M
Cash From Investing Activities -150.0K -160.0K 1.540M
Cash From Financing Activities 50.80M 1.980M -930.0K
Net Change In Cash 42.73M -6.390M -5.850M
YoY Change -11.71% 9.23% 111.96%
FREE CASH FLOW
Cash From Operating Activities -$7.920M -$8.210M -$6.460M
Capital Expenditures $150.0K $155.0K $187.0K
Free Cash Flow -$8.070M -$8.365M -$6.647M
YoY Change 5.91% 25.85% 81.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
65608391 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
244276923 shares
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
244276923 shares
CY2014Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
4.00
CY2014Q2 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
10000000
CY2014Q2 trxc Public Offering Number Of Shares To Be Sold
PublicOfferingNumberOfSharesToBeSold
12500000 shares
CY2014Q2 trxc Public Offering Over Allotment Option By Underwriter Shares
PublicOfferingOverAllotmentOptionByUnderwriterShares
1875000 shares
CY2014Q2 trxc Public Offering Expected Aggregate Gross Proceeds
PublicOfferingExpectedAggregateGrossProceeds
50000000
CY2014Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
4.00
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48855255 shares
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48855255 shares
CY2014Q2 trxc Public Offering Maximum Aggregate Offering Price
PublicOfferingMaximumAggregateOfferingPrice
100000000
CY2015Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2278000
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-146036000
CY2015Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
260519000
CY2015Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1626000
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
114547000
CY2015Q1 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
27259000
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4160000
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
64478085 shares
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
64478085 shares
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q1 us-gaap Liabilities Current
LiabilitiesCurrent
5444000
CY2015Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
8360000
CY2015Q1 us-gaap Common Stock Value
CommonStockValue
64000
CY2015Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
124000
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
128351000
CY2015Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2887000
CY2015Q1 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
279000
CY2015Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
107000
CY2015Q1 us-gaap Interest And Dividends Payable Current
InterestAndDividendsPayableCurrent
200000
CY2015Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2015Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
70000
CY2015Q1 us-gaap Notes Payable Current
NotesPayableCurrent
1540000
CY2015Q1 us-gaap Liabilities
Liabilities
13804000
CY2015Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
846000
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28376000
CY2015Q1 us-gaap Goodwill
Goodwill
93842000
CY2015Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3010000
CY2015Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
28626000
CY2015Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
250000
CY2015Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2116000
CY2015Q1 us-gaap Interest Receivable Current
InterestReceivableCurrent
1000
CY2015Q1 us-gaap Assets
Assets
128351000
CY2015Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
53000
CY2015Q1 us-gaap Cash
Cash
1117000
CY2015Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2123000
CY2015Q1 us-gaap Other Assets Current
OtherAssetsCurrent
644000
CY2015Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
52000
CY2015Q1 us-gaap Assets Current
AssetsCurrent
29074000
CY2015Q1 us-gaap Investments
Investments
0
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10014000
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
63182806 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
63182806 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
7000
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4147000
CY2014Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
9275000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
63000
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1768000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-135916000
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
257642000
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1769000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
121789000
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
60000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
135211000
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2762000
CY2014Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
208000
CY2014Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
145000
CY2014Q4 us-gaap Interest And Dividends Payable Current
InterestAndDividendsPayableCurrent
131000
CY2014Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
189000
CY2014Q4 us-gaap Notes Payable Current
NotesPayableCurrent
610000
CY2014Q4 us-gaap Liabilities
Liabilities
13422000
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1036000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34766000
CY2014Q4 us-gaap Goodwill
Goodwill
93842000
CY2014Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
33255000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3120000
CY2014Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
35016000
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
250000
CY2014Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2241000
CY2014Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
1000
CY2014Q4 us-gaap Assets
Assets
135211000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
133000
CY2014Q4 us-gaap Cash
Cash
1511000
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2248000
CY2014Q4 us-gaap Other Assets Current
OtherAssetsCurrent
789000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
62000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
35689000
CY2014Q4 us-gaap Investments
Investments
0
CY2014Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
7000
CY2014Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
52400000
CY2014Q2 trxc Stock Issued During Period Shares New Issues On Exercise Of Over Allotment Option By Underwriter
StockIssuedDuringPeriodSharesNewIssuesOnExerciseOfOverAllotmentOptionByUnderwriter
1610000 shares
CY2014Q2 trxc Issuance Costs On Issuance Of Common Stock
IssuanceCostsOnIssuanceOfCommonStock
4000000
CY2014Q2 trxc Stock Issued During Period Value New Issues On Exercise Of Over Allotment Option By Underwriter
StockIssuedDuringPeriodValueNewIssuesOnExerciseOfOverAllotmentOptionByUnderwriter
6400000
CY2014 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
CY2014Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.00 pure
CY2014Q1 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
22000
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5854000
CY2014Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
220000
CY2014Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
286000
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-930000
CY2014Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
125000
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1535000
CY2014Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8000
CY2014Q1 us-gaap Costs And Expenses
CostsAndExpenses
7251000
CY2014Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6459000
CY2014Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.2 pure
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
48850000 shares
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.15
CY2014Q1 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
938000
CY2014Q1 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-125000
CY2014Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-7479000
CY2014Q1 us-gaap Sales Revenue Net
SalesRevenueNet
93000
CY2014Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
178000
CY2014Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-50000
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7158000
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-321000
CY2014Q1 us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
5000
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
187000
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-7479000
CY2014Q1 us-gaap Interest Paid
InterestPaid
179000
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-136000
CY2014Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
CY2014Q1 us-gaap Interest Expense
InterestExpense
321000
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5011000
CY2014Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
406000
CY2014Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
1722000
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1614000
CY2014Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
54000
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
405000
CY2015Q1 dei Document Type
DocumentType
10-Q
CY2015Q1 dei Entity Registrant Name
EntityRegistrantName
TRANSENTERIX INC.
CY2015Q1 dei Trading Symbol
TradingSymbol
TRXC
CY2015Q1 dei Document Period End Date
DocumentPeriodEndDate
2015-03-31
CY2015Q1 dei Amendment Flag
AmendmentFlag
false
CY2015Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2015Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.00 pure
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-8214000
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
63745000 shares
CY2015Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000876378
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2015Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2015Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 Segment
CY2015Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
196000
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-9839000
CY2015Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-281000
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
155000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-10120000
CY2015Q1 us-gaap Interest Paid
InterestPaid
187000
CY2015Q1 us-gaap Costs And Expenses
CostsAndExpenses
9839000
CY2015Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1980000
CY2015Q1 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
CY2015Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
510000
CY2015Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-10120000
CY2015Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-143000
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-80000
CY2015Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
899000
CY2015Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
CY2015Q1 us-gaap Interest Expense
InterestExpense
281000
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7484000
CY2015Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
375000
CY2015Q1 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
12000
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6390000
CY2015Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
390000
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1979000
CY2015Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1783000
CY2015Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
15000
CY2015Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-143000
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-155000
CY2015Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
196000
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
899000
CY2015Q1 trxc Percent Of Holding Acquired Under Business Purchase Agreement
PercentOfHoldingAcquiredUnderBusinessPurchaseAgreement
0.93 pure
CY2015Q1 trxc Description Of Merger Agreement
DescriptionOfMergerAgreement
The Lock-up and Voting Agreements provide that such persons may sell, transfer or convey (i) up to 50% of their respective Covered Securities during the period commencing on the one-year anniversary of the Closing Date and ending on the eighteen-month anniversary of the Closing Date; and (ii) up to an aggregate of 75% of their respective Covered Securities during the period commencing on the eighteen-month anniversary of the Closing Date and ending on the two-year anniversary of the Closing Date.
CY2015Q1 trxc Estimated Annual Effective Income Tax Rate Continuing Operations
EstimatedAnnualEffectiveIncomeTaxRateContinuingOperations
0.00 pure
CY2015Q1 trxc Issuance Of Common Stock Net Of Issuance Costs
IssuanceOfCommonStockNetOfIssuanceCosts
1783000

Files In Submission

Name View Source Status
0001193125-15-174708-index-headers.html Edgar Link pending
0001193125-15-174708-index.html Edgar Link pending
0001193125-15-174708.txt Edgar Link pending
0001193125-15-174708-xbrl.zip Edgar Link pending
d910055d10q.htm Edgar Link pending
d910055dex101.htm Edgar Link pending
d910055dex311.htm Edgar Link pending
d910055dex312.htm Edgar Link pending
d910055dex321.htm Edgar Link pending
d910055dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
trxc-20150331.xml Edgar Link completed
trxc-20150331.xsd Edgar Link pending
trxc-20150331_cal.xml Edgar Link unprocessable
trxc-20150331_def.xml Edgar Link unprocessable
trxc-20150331_lab.xml Edgar Link unprocessable
trxc-20150331_pre.xml Edgar Link unprocessable